Newtown, PA-based BioClinica joins Covance, Icon, INC Research, InVentiv, Parexel, PPD and Quintiles as full members of the association, while King of Prussia, PA-based Theorem joins PRA Health Sciences as an associate member.
John Hubbard, President and CEO of BioClinica, will become a member of the ACRO Board of Directors. Hubbard has more than 30 years of experience in clinical research and drug development, most recently serving as Senior Vice President and Worldwide Head of Development Operations at Pfizer.
“I am delighted to welcome BioClinica and Theorem to the association and especially look forward to working with Dr. Hubbard on the ACRO Board,” said ACRO Chairman Jamie Macdonald, CEO of INC Research. “Our expanding membership is further evidence of the important role ACRO plays in promoting the interests of the CRO industry globally.”